[1] | LoVerde PT. Schistosomiasis[J]. Adv Exp Med Biol, 2019, 1154: 45-70. | [2] | Zhang LJ,, Xu ZM,, Yang F, et al. Endemic status of schistosomiasis in People’s Republic of China in 2020[J]. Chin J Schisto Control, 2021, 33(3): 225-233. (in Chinese) | [2] | ( 张利娟,, 徐志敏,, 杨帆, 等. 2020年全国血吸虫病疫情通报[J]. 中国血吸虫病防治杂志, 2021, 33(3): 225-233.) | [3] | Zhao J,, Chen Y,, Yu YR, et al. STAT3 promotes schistosome-induced liver injury by inflammation, oxidative stress, proliferation, and apoptosis signal pathway[J]. Infect Immun, 2021, 89(3): e00309-320. | [4] | Kong H,, He J,, Huang J, et al. Endothelin receptors promote schistosomiasis induced hepatic fibrosis via splenic B cells[J]. PLoS Pathog, 2020, 16(10): e1008947. | [5] | Zhou HH,, Lv NY,, Tong SJ, et al. Resveratrol regulates M1/M2 polarization of mice infected with Schistosoma japonicum through mitochondria[J]. Chin pharmacol Bull, 2021, 37(1):98-106. (in Chinese) | [5] | ( 周慧慧,, 吕年银,, 佟书娟, 等. 白藜芦醇通过线粒体调控血吸虫感染小鼠M1/M2极化[J]. 中国药理学通报, 2021, 37(1): 98-106.) | [6] | Zheng B,, Zhang JQ,, Chen H, et al. T lymphocyte mediated liver immunopathology of schistosomiasis[J]. Front Immunol, 2020, 11: 61. | [7] | Dorhoi A,, Glaría E,, Garcia-Tellez T, et al. MDSCs in infectious diseases: regulation roles, and readjustment[J]. Cancer Immunol Immun, 2019, 68(4): 673-685. | [8] | Yang ZZ,, Guo JC,, Weng LL, et al. Myeloid-derived suppressor cells-new and exciting players in lung cancer[J]. J Hematol Oncol, 2020, 13(1): 10. | [9] | Yin K,, Xia XL,, Rui K, et al. Myeloid-derived suppressor cells: a new and pivotal player in colorectal cancer progression[J]. Front Oncol, 2020, 10: 610104. | [10] | Veglia F,, Perego M,, Gabrilovich D. Myeloid-derived suppressor cells coming of age[J]. Nat Immunol, 2018, 19(2): 108-119. | [11] | Yang SH,, Kim J,, Lee MJ, et al. Abnormalities of plasma cytokines and spleen in senile APP/PS1/Tau transgenic mouse model[J]. Sci Rep, 2015, 5: 15703. | [12] | Aiello I,, Finkielstein CV,, Paladino N, et al. Circadian disruption promotes tumor-immune micro environment remodeling favoring tumor cell proliferation[J]. Sci Adv, 2020, 6(42): eaaz4530. | [13] | Liu D,, Wu J,, Cyster JG, et al. Requirements for cDC2 positioning in blood-exposed regions of the neonatal and adult spleen[J]. J Exp Med, 2020, 217(11): e20192300. | [14] | Lewis SM,, Williams A,, Eisenbarth SC. Structure and function of the immune system in the spleen[J]. Sci Immunol, 2019, 4(33): eaau6085. | [15] | Wang YJ,, Shen YJ,, Xu YX, et al. Observation on destroyed architecture of splenic lymphoid follicles in mice infected with Schistosoma japonicum by immunohistochemistry[J]. Chin J Schisto Control, 2017, 29(4): 468-470. (in Chinese) | [15] | ( 王燕娟,, 沈玉娟,, 徐馀信, 等. 免疫组化法观察日本血吸虫感染破坏小鼠脾脏淋巴滤泡结构[J]. 中国血吸虫病防治杂志, 2017, 29(4): 468-470.) | [16] | Tayukcuoglu E,, Horzum U,, Esendagli G, et al. Human splenic polymorphonuclear myeloid-derived suppressor cells (PMN-MDSC) are strategically located immune regulatory cells in cancer[J]. Eur J Immunol, 2020, 50(12): 2067-2074. | [17] | Corzo CA,, Cotter MJ,, Cheng PY, et al. Mechanism regulating reactive oxygen species in tumor-induced myeloid-derived suppressor cells[J]. J Immunol, 2009, 182(9): 5693-5701. | [18] | Weber R,, Groth C,, Lasser S, et al. IL-6 as a major regulator of MDSC activity and possible target for cancer immunotherapy[J]. Cell Immunol, 2021, 359: 104254. | [19] | Wang S,, Song R,, Ma J, et al. S100A8/A9 in inflammation[J]. Front Immunol, 2018, 9: 1298. | [20] | Ohl K,, Tenbrock K. Reactive oxygen species as regulators of MDSC-mediated immune suppression[J]. Front Immunol, 2018, 9: 2499. | [21] | Voronov E,, Dotan S,, Apte RN. IL-1-induced inflammation promotes development of leishmaniasis in susceptible BALB/c mice[J]. Int Immunol, 2010, 22(4): 245-257. | [22] | Van Ginderachter JA, Beschin A,, Raes G, et al. Myeloid-derived suppressor cells in parasitic infections[J]. Eur J Immunol, 2010, 40(11): 2976-2985. | [23] | Yang Q,, Qiu H,, Huang J, et al. A Schistosoma japonicum infection promotes the expansion of myeloid-derived suppressor cells by activating the JAK/STAT3 pathway[J]. J Immunol, 2017, 198(12): 4716-4727. | [24] | Gao YQ,, Li L,, Hu L, et al. Immuno-supressive function of myeloid derived suppressor cells to T cells in BALB/c mice infected with Schistosoma japonicum[J]. Chin J Immunol, 2019, 35(3): 269-273. (in Chinese) | [24] | ( 高勇强,, 黎丽,, 胡丽, 等. 日本血吸虫感染小鼠的髓源抑制细胞对T细胞的免疫抑制[J]. 中国免疫学杂志, 2019, 35(3): 269-273.) | [25] | Rasta JL,, Green WR. Myeloid-derived suppressor cells in murine AIDS inhibit B-cell responses in part via soluble mediators including reactive oxygen and nitrogen species, and TGF-β[J]. Virology, 2016, 499: 9-22. | [26] | Schwacha MG,, Scroggins SR,, Cap AP, et al. Bum injury is associated with an infiltration of the wound site with myeloid-derived suppressor cells[J]. Cell Immunol, 2019, 338: 21-26. |
|